Vitamin C, Hydrocortisone and Thiamine in Patients With Septic Shock
Vitamin C, Hydrocortisone and Thiamine in Patients With Septic Shock: a Randomized Clinical Study (VITAMIN TRIAL)
Sponsor: Hospital Sirio-Libanes
Terminated
In order to preserve the safety of the patients and prevent any harm from occurring, we opted to discontinue the study based on previous results (LOVIT study) published at 2022. Were recruited 71 than 1090 participants.
Other terminated trials from Hospital Sirio-Libanes
Other Sepsis trials with similar outcome
Listed as NCT05192213, this PHASE3 trial focuses on Sepsis and Septic Shock and remains terminated or withdrawn. Sponsored by Hospital Sirio-Libanes, it has been updated 6 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Feb 2024 — Jul 2024 [monthly]
Terminated PHASE3
Status: Unknown Status → Terminated
-
Jan 2024 — Feb 2024 [monthly]
Unknown Status PHASE3
Status: Recruiting → Unknown Status
▶ Show 1 earlier version
-
Feb 2022 — Jan 2024 [monthly]
Recruiting PHASE3
First recorded
Aug 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hospital Sirio-Libanes
- Ministry of Health, Brazil
- PROADI-SUS
For direct contact, visit the study record on ClinicalTrials.gov .